MoneyWorks4Me

Ajanta Pharma - Quaterly Results

27 Jul 2023 Evaluate
A fair growth of 19.32% in the revenue at Rs. 10145.80 millions was reported in the June 2023 quarter as compared to Rs. 8502.90 millions during year-ago period.A good growth in profit of 41.01% reported to Rs. 2120.40  millions over Rs. 1503.70 millions of corresponding previous quarter.Operating profit surged to 3083.60 millions from the corresponding previous quarter of 2217.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 10145.80 8502.90 19.32 10145.80 8502.90 19.32 34112.70 31406.40 8.62
Other Income 314.60 354.20 -11.18 314.60 354.20 -11.18 1327.50 1397.30 -5.00
PBIDT 3083.60 2217.30 39.07 3083.60 2217.30 39.07 8320.30 10306.20 -19.27
Interest 7.50 6.30 19.05 7.50 6.30 19.05 52.30 91.20 -42.65
PBDT 3076.10 2211.00 39.13 3076.10 2211.00 39.13 8268.00 10215.00 -19.06
Depreciation 322.40 307.50 4.85 322.40 307.50 4.85 1269.50 1209.60 4.95
PBT 2753.70 1903.50 44.67 2753.70 1903.50 44.67 6998.50 9005.40 -22.29
TAX 633.30 399.80 58.40 633.30 399.80 58.40 1411.30 1806.80 -21.89
Deferred Tax 27.50 -18.30 -250.27 27.50 -18.30 -250.27 -29.30 95.10 -130.81
PAT 2120.40 1503.70 41.01 2120.40 1503.70 41.01 5587.20 7198.60 -22.38
Equity 252.70 257.10 -1.71 252.70 257.10 -1.71 252.70 171.70 47.18
PBIDTM(%) 30.39 26.08 16.55 30.39 26.08 16.55 24.39 32.82 -25.67
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..